4d Molecular Therapeutics Stock Market Value
| FDMT Stock | USD 7.62 0.17 2.18% |
| Symbol | FDMT |
4D Molecular Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 4D Molecular. If investors know FDMT will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 4D Molecular listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.85) | Quarterly Revenue Growth (1.00) | Return On Assets (0.17) | Return On Equity (0.24) |
The market value of 4D Molecular Therapeutics is measured differently than its book value, which is the value of FDMT that is recorded on the company's balance sheet. Investors also form their own opinion of 4D Molecular's value that differs from its market value or its book value, called intrinsic value, which is 4D Molecular's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 4D Molecular's market value can be influenced by many factors that don't directly affect 4D Molecular's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 4D Molecular's value and its price as these two are different measures arrived at by different means. Investors typically determine if 4D Molecular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 4D Molecular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
4D Molecular 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to 4D Molecular's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of 4D Molecular.
| 12/07/2022 |
| 11/26/2024 |
If you would invest 0.00 in 4D Molecular on December 7, 2022 and sell it all today you would earn a total of 0.00 from holding 4D Molecular Therapeutics or generate 0.0% return on investment in 4D Molecular over 720 days. 4D Molecular is related to or competes with Eliem Therapeutics, HCW Biologics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-asso... More
4D Molecular Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure 4D Molecular's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess 4D Molecular Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.24) | |||
| Maximum Drawdown | 25.71 | |||
| Value At Risk | (5.78) | |||
| Potential Upside | 5.15 |
4D Molecular Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for 4D Molecular's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as 4D Molecular's standard deviation. In reality, there are many statistical measures that can use 4D Molecular historical prices to predict the future 4D Molecular's volatility.| Risk Adjusted Performance | (0.15) | |||
| Jensen Alpha | (0.82) | |||
| Total Risk Alpha | (1.51) | |||
| Treynor Ratio | 2.59 |
4D Molecular Therapeutics Backtested Returns
4D Molecular Therapeutics retains Efficiency (Sharpe Ratio) of -0.25, which signifies that the company had a -0.25% return per unit of price deviation over the last 3 months. 4D Molecular exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm 4D Molecular's Information Ratio of (0.24), market risk adjusted performance of 2.6, and Variance of 17.16 to double-check the risk estimate we provide. The firm owns a Beta (Systematic Risk) of -0.33, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning 4D Molecular are expected to decrease at a much lower rate. During the bear market, 4D Molecular is likely to outperform the market. At this point, 4D Molecular Therapeutics has a negative expected return of -1.01%. Please make sure to confirm 4D Molecular's information ratio, as well as the relationship between the potential upside and rate of daily change , to decide if 4D Molecular Therapeutics performance from the past will be repeated sooner or later.
Auto-correlation | 0.55 |
Modest predictability
4D Molecular Therapeutics has modest predictability. Overlapping area represents the amount of predictability between 4D Molecular time series from 7th of December 2022 to 2nd of December 2023 and 2nd of December 2023 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of 4D Molecular Therapeutics price movement. The serial correlation of 0.55 indicates that about 55.0% of current 4D Molecular price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.55 | |
| Spearman Rank Test | 0.62 | |
| Residual Average | 0.0 | |
| Price Variance | 52.04 |
4D Molecular Therapeutics lagged returns against current returns
Autocorrelation, which is 4D Molecular stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting 4D Molecular's stock expected returns. We can calculate the autocorrelation of 4D Molecular returns to help us make a trade decision. For example, suppose you find that 4D Molecular has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
4D Molecular regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If 4D Molecular stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if 4D Molecular stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in 4D Molecular stock over time.
Current vs Lagged Prices |
| Timeline |
4D Molecular Lagged Returns
When evaluating 4D Molecular's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of 4D Molecular stock have on its future price. 4D Molecular autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, 4D Molecular autocorrelation shows the relationship between 4D Molecular stock current value and its past values and can show if there is a momentum factor associated with investing in 4D Molecular Therapeutics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for FDMT Stock Analysis
When running 4D Molecular's price analysis, check to measure 4D Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4D Molecular is operating at the current time. Most of 4D Molecular's value examination focuses on studying past and present price action to predict the probability of 4D Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4D Molecular's price. Additionally, you may evaluate how the addition of 4D Molecular to your portfolios can decrease your overall portfolio volatility.